Thus, in their study, Herrscher et al. [12] showed that the M protein peptide demonstrated a greater difference in reactivity between serum samples from COVID-19 patients and samples from the pre-COVID-19 period (2018). The gene discussed is MYOM2; the disease is COVID-19.